ArticleJournal of hepatocellular carcinoma2024

Prognosis of Neoadjuvant HAIC and Lenvatinib Followed by Surgery versus Direct Resection for Resectable or Borderline Resectable Hepatocellular Carcinoma: A Real-World Study.

Yuan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.